ResMed Inc (NYSE:RMD)
| 50.02 Data as of May 23 |  +0.30 / +0.60%Today’s Change | 29.82 Today|||52-Week Range 51.40 | +20.33% Year-to-Date |
Latest RMD News | Press Releases
No recent news for ResMed Inc.
Today’s Trading
| Previous close | 49.72 |
| Today’s open | 49.49 |
| Day’s range | -- - -- |
| Volume | 777,039 |
| Average volume (3 months) | 1,019,353 |
| Market cap | $7.1B |
| Dividend yield | 1.36% |
Data as of 4:06pm ET, 05/23/2013
Growth & Valuation
| Earnings growth (last year) | +18.75% |
| Earnings growth (this year) | +25.95% |
| Earnings growth (next 5 years) | +15.30% |
| Revenue growth (last year) | +10.08% |
| P/E ratio | 23.5 |
| Price/Sales | 3.33 |
| Price/Book | 4.42 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| VARVarian Medical Syste... | -0.54 | -0.79% |
| TFXTeleflex Inc | +0.32 | +0.41% |
| THORThoratec Corp | +0.55 | +1.78% |
| HTWRHeartWare Internatio... | -0.12 | -0.13% |
Data as of 4:09pm ET, 05/23/2013
Financials
| Next reporting date | August 8, 2013 |
| EPS forecast (this quarter) | $0.62 |
| Annual revenue (last year) | $1.4B |
| Annual profit (last year) | $254.9M |
| Net profit margin | 18.62% |
Profile
Sector Health Technology |
Industry Medical Specialties |
Executive Chairman Peter C. Farrell, PhD |
President & Chief Operating Officer Robert Andrew Douglas, MBA |
Corporate headquarters San Diego, California |
Forecasts
